Class II recall: Heritage Pharmaceuticals Inc: CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only,
FDA classified a Class II recall for Heritage Pharmaceuticals' Clindamycin Palmitate Hydrochloride for Oral Solution, USP, 75 mg/5 mL (100 mL bottles, NDC 23155-603-51), distributed by Avet Pharmaceuticals Inc. The recall notice cites the presence of particles and white flakes found in reconstituted bottles of the product.
Most relevant for: Children requiring oral clindamycin treatment who may have received affected bottles of this medication
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More pediatrics updates
- Broad-spectrum antibiotics show no benefit for CAP in complex childrenOct 7, 2026
- AAP Policy Statement Addresses Infection Risks of Raw MilkOct 5, 2026
- Commercial pediatric sepsis alert shows low sensitivity in ED studyOct 5, 2026
- Multi-condition care pathways boost guideline adherence in general hospitalsOct 1, 2026
- AAP revises pediatric UTI diagnostic definition for 2026 guidelineOct 1, 2026